Search

everythinglearnresearchcommunity

for

Search:↓

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Targeting specific miRNAs may help treat hair follicle issues caused by hydrogen peroxide.

The document is a detailed medical reference on skin and genetic disorders.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Spironolactone might lower the chance of getting rosacea.

Researchers created human hair follicles using a new method that could help treat hair loss.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Anticonvulsant drugs may cause temporary chromosomal abnormalities.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Bioluminescence imaging can track hair follicle cells and help study hair regrowth.

Finasteride may help prevent chronic bacterial prostatitis, with better results when combined with antibiotics.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The document concludes that pig iPSCs show promise for transplant therapies and the field is advancing in controlling cell behavior for biology and medicine.

The document suggests that hair loss after stopping birth control may be similar to post-pregnancy hair loss and could recur with future pregnancies.

Polymer dot nanozymes and exosomes, with laser stimulation, speed up wound healing.

Spironolactone is effective and safe for treating acne.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.